Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca 2+ signaling in rat

Journal of Bioenergetics and Biomembranes

Volumn 43, Issue 6, 2011, Pages 747-756

  Tuncay, Erkan ^a   Zeydanli, Esma N ^a   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Beta blockers; Diabetic cardiomyopathy; Heart; Intracellular calcium ion homeostasis; Sarcoplasmic reticulum dysfunction

Indexed keywords

PROPRANOLOL; RYANODINE RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; HEART FUNCTION; HEART PAPILLARY MUSCLE; HYPOGLYCEMIA; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; CALCIUM SIGNALING; CARDIOTONIC AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; PROPRANOLOL; RATS; RATS, WISTAR; STREPTOZOCIN; VENTRICULAR REMODELING;

RATTUS;

EID: 84857053110     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-011-9400-5     Document Type: Article

References (38)

1. Ahmet I, Krawczyk M, Zhu W, Woo AY, Morrell C, Poosala S, Xiao RP, Lakatta EG, Talan MI (2008) Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction. J Pharmacol Exp Ther 325(2):491-499 (Pubitemid 351574789)
2. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Gentile G, Reboldi G (2010) β-blockers reduce mortality in patients undergoing high-risk non-cardiacsurgery. Am J Cardiovasc Drugs 10(4):247-259
3. Aydemir-Koksoy A, Bilginoglu A, Sariahmetoglu M, Schulz R, Turan B (2010) Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. J Nutr Biochem 21(9):827-833
4. Bidasee KR, Nallani K, Besch HR Jr, Dincer UD (2003) Streptozotocin- induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2). J Pharmacol Exp Ther 305(3):989-998 (Pubitemid 36617976)
5. Bilginoglu A, Seymen A, Tuncay E, Zeydanli E, Aydemir-Koksoy A, Turan B (2009) Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats. CardiovascToxicol 9(1):21-29
6. Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA (2002) Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283(4): H1398-H1408
7. Communal C, Singh K, Sawyer DB, Colucci WS (1999) Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100(22):2210-2212
8. Conlon D, Johnston A, O'Malley K, Turner P, Kilfeather S (1995) Effect of ageing and propranolol administration on myocardial beta-adrenoceptor receptor function in mature rats. Eur JPharmacol 289(2):283-290
9. Djanani A, Kaneider NC, Meierhofer C, Sturn D, Dunzendorfer S, Allmeier H, Wiedermann CJ (2003) Inhibition of eutrophil migration and oxygen free radical release by metipranolol and timolol. Pharmacology 68(4):198-203 (Pubitemid 36831227)
10. Doi M, Yano M, Kobayashi S, Kohno M, Tokuhisa T, Okuda S, Suetsugu M, Hisamatsu Y, Ohkusa T, Kohno M, Matsuzaki M (2002) Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor. Circulation 105(11):1374-1379 (Pubitemid 34260431)
11. Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH (1980) Altered myocardial mechanics in diabetic rats. Circ Res 47(6):922-933 (Pubitemid 11217058)
12. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS (1983) Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 244(6):E528-E535 (Pubitemid 13067062)
13. Guatimosim S, Dilly K, Santana LF, SaleetJafri M, Sobie EA, Lederer WJ (2002) Local Ca(2+) signaling and EC coupling in heart: Ca (2+) sparks and the regulation of the [Ca(2+)](i) transient. J MolCell Cardiol 34(8):941-950 (Pubitemid 35316142)
14. Hjalmarson A, Goldstein S, Fagerberg B et al (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/ XL randomized intervention trial in congestive heart failure (MERIT-HF). MERIT-HF study group. JAMA 283(10):1295-1302 (Pubitemid 30129796)
15. Kandilci HB, Tuncay E, Zeydanli EN, Sozmen NN, Turan B (2011) Age-related regulation of excitation-contraction coupling in rat heart. J Physiol Biochem 67(3):317-330
16. Kubo H, Margulies KB, Piacentino V 3rd, Gaughan JP, Houser SR (2001) Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 104(9):1012-1018 (Pubitemid 32803877)
17. López-López JR, Shacklock PS, Balke CW, Wier WG (1995) Local calcium transients triggered by single L-type calcium channel currents in cardiac cells. Science 268(5213):1042-1045
18. Magyar J, Rusznák Z, Szentesi P, Szûcs G, Kovács L (1992) Action potentials and potassium currents in rat ventricular muscle during experimental diabetes. J Mol Cell Cardiol 24(8):841-853
19. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR (2000) PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (4):365-376
20. Metra M, Covolo L, Pezzali N et al (2010) Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of betablockade with carvedilol in patients with chronic heart failure. Cardiovasc Drugs Ther 24(1):49-60
21. Miyamoto N, Izumi H, Miyamoto R, Kubota T, Tawara A, Sasaguri Y, Kohno K (2009) Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress. Invest Ophthalmol Vis Sci 50(6):2777-2784
22. Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M (2007) Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 49(16):1722-1732 (Pubitemid 46589924)
23. Pierce GN, Kutryk MJ, Dhalla NS (1983) Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc NatlAcadSci USA 80(17):5412-5416 [PubMed: 6577435] (Pubitemid 13050231)
24. Reiken S, Wehrens XH, Vest JA, Barbone A, Klotz S, Mancini D, Burkhoff D, Marks AR (2003) Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107(19):2459-2466 (Pubitemid 36605229)
25. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6):595-602
26. Shan J, Betzenhauser MJ, Kushnir A, Reiken S, Meli AC, Wronska A, Dura M, Chen BX, Marks AR (2010) Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice. J Clin Invest 120(12):4375-4387
27. Sharma V, Dhillon P, Wambolt R, Parsons H, Brownsey R, Allard MF, McNeill JH (2008) Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. Am J Physiol Heart Circ Physiol 294(4):H1609-H1620 (Pubitemid 351490590)
28. Sozmen NN, Tuncay E, Bilginoglu A, Turan B (2011) Profound cardioprotection with timolol in a female rat model of agingrelated altered left ventricular function. Can J Physiol Pharmacol 89(4):277-288
29. Tuncay E, Seymen AA, Tanriverdi E, Yaras N, Tandogan B, Ulusu NN, Turan B (2007) Gender related differential effects of omega- 3E treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem 304(1-2):255-263 (Pubitemid 47456874)
30. Tuncay E, Seymen AA, Sam P, Gurdal H, Turan B (2009) Effects of beta-adrenergic receptor blockers on cardiac function: a comparative study in male versus female rats. Can J Physiol Pharmacol 87(4):310-317
31. Turan B, Désilets M, Açan LN, Hotomaroglu O, Vannier C, Vassort G (1996) Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc Res 32(2):351-361 (Pubitemid 26246882)
32. Ulusu NN, Turan B (2005) Beneficial effects of selenium on some enzymes of diabetic rat heart. Biol Trace Elem Res 103(3):207-216
33. Wang R, Miura T, Harada N, Kametani R, Shibuya M, Fukagawa Y, Kawamura S, Ikeda Y, Hara M, Matsuzaki M (2006) Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes. J Pharmacol Exp Ther 318(1):45-52
34. Wehrens XH, Marks AR (2003) Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends Biochem Sci 28(12):671-678 (Pubitemid 37500902)
35. Yaras N, Ugur M, Ozdemir S, Gurdal H, Purali N, Lacampagne A, Vassort G, Turan B (2005) Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes 54(11):3082-3088 (Pubitemid 43334359)
36. Yaras N, Tuncay E, Purali N, Sahinoglu B, Vassort G, Turan B (2007) Sex-related effects on diabetes-induced alterations in calcium release in the rat heart. Am J Physiol Heart Circ Physiol 293(6): H3584-H3592 [PubMed: 17890429] (Pubitemid 350230903)
37. Yoshida A, Takahashi M, Imagawa T, Shigekawa M, Takisawa H, Nakamura T (1992) Phosphorylation of ryanodine receptors in rat myocytes during beta-adrenergic stimulation. J Biochem 111 (2):186-190
38. Zeydanli EN, Kandilci HB, Turan B (2011) Doxycycline ameliorates vascular endothelial and contractile dysfunction in the thoracic aorta of diabetic rats. CardiovascToxicol 11(2):134-147